North America Neurosurgery Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Neurosurgery Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Published Report
  • Sep 2022
  • North America
  • 350 Pages
  • No of Tables: 55
  • No of Figures: 39

North America Neurosurgery Market, By Product Type (Neurosurgery Devices, Neurosurgery Software, Consumables), Application (Aneurysms, Arteriovenous Malformation (AVM), Brain Tumors, Carotid Artery Blockage/Stenosis, Cerebrovascular Surgery, Cortical Mapping, Epilepsy, Functional Neurosurgery, Intraoperative Angiography, Parkinson's Disease and Tremors, Peripheral Nerve Surgery, Pituitary Tumors, Radiosurgery, Skull Base Surgery, Spine Surgery, Stereotactic Neurosurgery, Trauma Surgery, Trigeminal Neuralgia, Others), Age Group (Pediatric, Adult, Geriatric), End User (Hospitals, Neurosurgery Centers, Research Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Third Party Distributors, Others) Industry Trends and Forecast to 2029

North America Neurosurgery Market

North America Neurosurgery Market Analysis and Insights

Technological innovation within healthcare may be defined as the introduction of a new technology that initiates a change in clinical practice. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. The present focus is on developing minimally-invasive devices that could decrease the probability of complications during operative sessions. With the introduction of minimally-invasive techniques, doctors are using highly specialized surgical instruments such as power tools, neurovascular embolization devices, and radiosurgery systems such as gamma-knife.

North America Neurosurgery Market

North America Neurosurgery Market

In addition, a set of new factors, such as enhanced regulatory standards and an increasing incidence of neurological diseases, has led to an increase in the adoption of advanced treatment protocols and the assumption that such therapies will be available more widely. This has increased industry and government demand for zero deviations, which has driven the demand for neurosurgical services, and an increase in cross-industry alliances and collaborations is a major factor expected to boost the neurosurgery market. However, the higher costs involved in neuro endoscopy equipment and procedures, along with the lack of trained professionals, may restrain the market growth in the forecast period.

Data Bridge Market Research analyzes that the North America neurosurgery market is expected to reach a value of USD 9,332.21 million by 2029, at a CAGR of 14.3% during the forecast period. "Product type" accounts for the largest type segment in the market due to the increasing patient population in the North America region. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2015)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Product Type (Neurosurgery Devices, Neurosurgery Software, Consumables), Application (Aneurysms, Arteriovenous Malformation (AVM), Brain Tumors, Carotid Artery Blockage/Stenosis, Cerebrovascular Surgery, Cortical Mapping, Epilepsy, Functional Neurosurgery, Intraoperative Angiography, Parkinson's Disease and Tremors, Peripheral Nerve Surgery, Pituitary Tumors, Radiosurgery, Skull Base Surgery, Spine Surgery, Stereotactic Neurosurgery, Trauma Surgery, Trigeminal Neuralgia, Others), Age Group (Pediatric, Adult, Geriatric), End User (Hospitals, Neurosurgery Centers, Research Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Third Party Distributors, Others)

Countries Covered

U.S., Canada, Mexico

Market Players Covered

Medtronic, Abbott, Boston Scientific Corporation, Elekta, ALEVA NEUROTHERAPEUTICS, Brainlab AG, adeor medical AG, LivaNova PLC, B. Braun SE, Terumo Medical Corporation, Integra LifeSciences, Stryker, Penumbra, Inc., KARL STORZ SE & Co. KG, Renishaw plc., Inomed Medizintechnik GmbH, ANT Neuro, and Leica Microsystems among others

North America Neurosurgery Market Definition

The neurological conditions include dementia, headache disorders, neuro-infections, and multiple sclerosis, traumatic brain injuries, pain associated with neurological disorders, neurological disorders associated with malnutrition, stroke, epilepsy, and Parkinson's disease. These disorders are fatal and cannot be cured by therapeutics. Some of the neurosurgery devices are neuro-endoscopes, stereotactic systems, catheters, pacemakers, single- and dual-chamber defibrillators, and implantable cardioverter defibrillators among others, that are used in a variety of neurosurgical procedures. Neurosurgery aids in the diagnosis of patients who have brain tumors, spinal cord injuries brought by accidents, neck and back discomfort, and abnormal spinal fluid movement. Around 7 to 10 million people worldwide suffer from Parkinson's disease. Neurological illness is one of the main causes of morbidity and disability worldwide. During the forecast period, technological developments in neurosurgery are anticipated to drive the market. The rise in incidences and prevalence of neurological conditions within the population and the advantage of neurosurgery over other conventional surgeries are expected to boost the growth of the neurosurgery market across the globe. In addition, advances in neurological surgeries such as 3-dimension reconstruction for brain tumor surgery, X-knife radiosurgery for brain lesions, MRI for brain tumors, and surgery under local anesthesia for brain tumors are anticipated to provide lucrative opportunities for the growth of the neurosurgery market.

North America Neurosurgery Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

  • Technological advancement in neurosurgery

Since the beginning of modern neurosurgery, technological advancements have paved the way for a more thorough and enhanced understanding of cerebral form and function to more effectively treat complex pathologies affecting patients. Technological advancements brought a transition from conventional equipment toward energy-efficient equipment based on novel technology. Several cutting-edge techniques help neurosurgeries quite easily. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. Image guidance and neuromodulation devices demonstrated a highly correlated rapid rise in patents and publications, suggesting they are areas of technology expansion which is expected to boost the market growth.

With the growth in the prevalence of neurological conditions, the demand for neurosurgery is also increasing. The market is expected to grow in the forecast period.

Moreover, the adoption of endoscopic techniques' is a significant market advancement. Additionally, recovery time is shorter in neurosurgeries. Thus, all these factors are expected to act as drivers for market growth.

  • Rising prevalence of neurological conditions

The World Health Organization (WHO) focuses on research in areas that are important for public health promotion. Recently, WHO has been particularly interested in frequent and disabling neurological disorders with a high burden on the world? Neurological disorders occur among all age groups and different geographical regions. They significantly contribute to morbidity and mortality around the world. The neurological burden of disease is expected to grow exponentially in low- and middle-income countries (LMICs) in the next decade.

The rising prevalence of neurological conditions such as transnasal hemorrhage, intracerebral hemorrhage (ICH), traumatic brain injury, chronic pain, depression, and Parkinson's is expected to drive market growth.

Thus, increasing neurological disorders such as transnasal hemorrhage and intracerebral hemorrhage (ICH) are fueling market growth. Neurological conditions have become a major public health crisis which is expected to boost the growth of the North America neurosurgery market.

Restraint

  • The high cost associated with neurosurgeries and equipment

A significant increase in the cost of neurosurgical products has been observed in recent years, which end users such as hospitals and neurosurgical centers have to incur. Products such as neurovascular embolization devices, neurovascular coiling devices, and neuroendoscopes are quite costly. Manufacturers are also giving more resources to research and development to introduce cost-effective and advanced technology. Some complex neurosurgeries require extensive time as well as effort, and they are also quite risky. These complex procedures need advanced techniques and skills, and because of this, the cost of equipment and neurosurgeries increases. The maintenance of such facilities and continuous requirement of power supply add up to the cost of the surgeries. Decompressive craniectomy for traumatic brain injury (TBI) is an expensive procedure that is also associated with high morbidity and mortality.

The cost associated with neurosurgery procedures is quite high, which is expected to act as a restrain for the market growth.

Opportunity

  • Rising awareness about neurological disorders

With the rising North America population, a large portion of the geriatric section is getting affected with neurological disorders such as epilepsy, Parkinson's disease, stroke, brain tumor, dementia, and multiple sclerosis, among others. So, understanding neurological disorders is important, and awareness about neurological conditions can lead to seeking medical attention, which results in proper diagnosis and effective treatment. All neurological disorders account for 82.8%. The massive fold increases the burden of neurological disorders that can be attributed to a lack of awareness about neurological disorders and treatment, which lead to delayed detection, and lack of access to quality healthcare and rehabilitation centers. Rising healthcare programs and increasing funding from governments and public healthcare agencies help reduce the burden of neurological disorders and develop neurological products that act in favor of market growth.

Rising awareness about neurological disorders is beneficial for the neurosurgery market. In most regions, many governmental and non-governmental are carry some awareness programs for the early detection of neurological conditions.

Challenge

  • Alternative treatments for neurological disease

Drug therapies are the first line of treatment for the treatment of neurological conditions. Neurosurgical procedures are opted only if non-surgical treatments are not effective. Complementary and alternative treatments are increasingly employed to supplement neurosurgical treatment in neurosurgery. This includes acupuncture, naturopathic medicine, chiropractic treatment, and ayurvedic medicine among others. More recently, doctors have become increasingly receptive to the use of alternative treatments, and scientific studies on the safety and effectiveness of complementary and alternative options are taken through the national institutes of health, which may act as a challenge to the growth of the neurosurgery market.

Thus, alternative treatment options are expected to offer significant challenges for the North America neurosurgical market. 

Post-COVID-19 Impact on North America Neurosurgery Market

The COVID-19 outbreak had a drastic effect on North America healthcare, with the U.S. amongst the countries most severely impacted. The pandemic has had a negative impact on the neurosurgery market growth on account of the temporary halt in research activities in this field, coupled with the low influx of patients in hospitals and diagnostic centers. Moreover, the impact of COVID-19 pandemic on neurosurgical products delivery is challenging the neurosurgeons for getting delivery of surgical products.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology in the neurosurgery market.

Recent Developments

  • In March 2022, Medtronic, a leader in healthcare technology, announced their first patient implants in the TITAN 2 pivotal study that evaluated the safety and efficacy of Medtronic's investigational implantable tibial neuromodulation (TNM) device in people with overactive bladder (OAB). Implantable TNM has the potential to give relief to millions who suffer from bladder incontinence through a new approach that provides greater convenience and more options for physicians and patients. This will help the company to evaluate the safety and efficacy of its products
  • In April 2022, Abbott announced that it had launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality that will help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain. This upgrade is part of Abbott's commitment to connected care technology and is intended to put people in control of their health and facilitate better communication with their doctors. This has helped the company to enhance its product use by launching the app

North America Neurosurgery Market Scope

The North America neurosurgery market is segmented into product type, application, age group, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

By Product Type

  • Neurosurgery devices
  • Neurosurgery software
  • Consumables

On the basis of product type, the North America neurosurgery market is segmented into neurosurgery devices, neurosurgery software, and consumables.

By Application

  • Aneurysms
  • Arteriovenous malformation (AVM)
  • Brain tumors
  • Carotid artery blockage/stenosis
  • Cerebrovascular surgery
  • Cortical mapping
  • Epilepsy
  • Functional neurosurgery
  • Intraoperative angiography
  • Parkinson's disease and tremors
  • Peripheral nerve surgery
  • Pituitary tumors
  • Radiosurgery
  • Skull base surgery
  • Spine surgery
  • Stereotactic neurosurgery
  • Trauma surgery
  • Trigeminal neuralgia
  • Others

On the basis of application, the North America neurosurgery market is segmented into aneurysms, arteriovenous malformation (AVM), brain tumors, carotid artery blockage/stenosis, cerebrovascular surgery, cortical mapping, epilepsy, functional neurosurgery, intraoperative angiography, Parkinson's disease and tremors, peripheral nerve surgery, pituitary tumors, radiosurgery, skull base surgery, spine surgery, stereotactic neurosurgery, trauma surgery, trigeminal neuralgia, others.

By Age Group

  • Pediatric
  • Adult
  • Geriatric

On the basis of end user, the North America neurosurgery market is segmented into pediatric, adult, and geriatric.

By End User

  • Hospitals
  • Research centers
  • Neurosurgery centers
  • Ambulatory surgical centers (ASCS)
  • Others

On the basis of end user, the North America neurosurgery market is segmented into hospitals, neurosurgery centers, research centers, ambulatory surgical centers, and others

By Distribution Channel

  • Direct tender
  • Third party distributors
  • Others

Neurosurgery Market

On the basis of distribution channel, the North America neurosurgery market is segmented into direct tender, third party distributors, and others.

North America Neurosurgery Market Regional Analysis/Insights

The North America neurosurgery market is analyzed, and market size information is provided by product type, application, age group, end user, and distribution channel.

The countries covered in this market report are U.S., Canada, and Mexico.

In 2022, North America is expected to dominate due to the presence of key market players in the largest consumer market with high GDP. The U.S is expected to dominate the North America neurosurgery market and grow due to the rise in technological advancement in neurosurgical equipment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Neurosurgery Market Share Analysis

North America neurosurgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus on the North America neurosurgery market.

Some of the major players operating in the North America neurosurgery market are Medtronic, Abbott, Boston Scientific Corporation, Elekta, ALEVA NEUROTHERAPEUTICS, Brainlab AG, adeor medical AG, LivaNova PLC, B. Braun SE, Terumo Medical Corporation, Integra LifeSciences, Stryker, Penumbra, Inc., KARL STORZ SE & Co. KG, Renishaw plc., Inomed Medizintechnik GmbH, ANT Neuro, and Leica Microsystems among others.

Research Methodology: North America Neurosurgery Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, North America vs Regional, and Vendor Share Analysis. Please request an analyst call in case of further inquiry.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA NEUROSURGERY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 SOURCE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 INDUSTRIAL INSIGHTS:

4.4 CONCLUSION

5 REGULATIONS OF THE NORTH AMERICA NEUROSURGERY MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TECHNOLOGICAL ADVANCEMENT IN NEUROSURGERY

6.1.2 RISING PREVALENCE OF NEUROLOGICAL CONDITIONS

6.1.3 DEVELOPMENTS IN SURGICAL EQUIPMENT

6.2 RESTRAINTS

6.2.1 THE HIGH COST ASSOCIATED WITH NEUROSURGERIES AND EQUIPMENT

6.2.2 UNFAVOURABLE REIMBURSEMENT POLICIES

6.3 OPPORTUNITIES

6.3.1 RISING AWARENESS ABOUT NEUROLOGICAL DISORDERS

6.3.2 INCREASING NUMBER OF KEY PLAYERS IN MARKET

6.3.3 ADVANCE PRODUCT DEVELOPMENT AND LAUNCHES IN RECENT YEARS

6.4 CHALLENGES

6.4.1 ALTERNATIVE TREATMENTS FOR NEUROLOGICAL DISEASE

6.4.2 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES

7 NORTH AMERICA NEUROSURGERY MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 NEUROSURGERY DEVICES

7.2.1 NEUROMODULATION DEVICES

7.2.1.1 INTERNAL NEUROMODULATION DEVICES

7.2.1.1.1 SPINAL CORD STIMULATION DEVICES

7.2.1.1.1.1 RECHARGEABLE

7.2.1.1.1.2 NON- RECHARGEABLE

7.2.1.1.2 DEEP BRAIN STIMULATION DEVICES

7.2.1.1.2.1 SINGLE-CHANNEL DEEP BRAIN STIMULATION

7.2.1.1.2.2 DUAL-CHANNEL DEEP BRAIN STIMULATION

7.2.1.1.3 SACRAL NERVE STIMULATION DEVICES

7.2.1.1.3.1 IMPLANTABLE

7.2.1.1.3.2 EXTERNAL

7.2.1.1.4 VAGUS NERVE STIMULATION DEVICES

7.2.1.1.4.1 INVASIVE

7.2.1.1.4.2 EXTERNAL

7.2.1.1.5 GASTRIC ELECTRICAL STIMULATION DEVICES

7.2.1.1.5.1 LOW FREQUENCY GASTRIC ELECTRICAL STIMULATORS

7.2.1.1.5.2 HIGH FREQUENCY GASTRIC ELECTRICAL STIMULATORS

7.2.1.1.6 EXTERNAL NEUROMODULATION DEVICES

7.2.1.1.6.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)

7.2.1.1.6.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)

7.2.1.1.6.3 OTHERS

7.2.2 NEURO-INTERVENTIONAL DEVICES

7.2.2.1 EMBOLIZATION COILS

7.2.2.1.1 DETACHABLE

7.2.2.1.2 PUSHABLE

7.2.2.2 CAROTID STENTS

7.2.2.3 INTRACRANIAL STENTS

7.2.2.4 NEUROVASCULAR THROMBECTOMY

7.2.2.4.1 COIL RETRIEVERS

7.2.2.4.2 ASPIRATION DEVICES

7.2.2.4.3 STENT RETRIEVERS

7.2.2.5 INTRASSACULAR DEVICES

7.2.2.6 BALLOONS

7.2.2.7 OTHERS

7.2.3 NEUROSURGERY SURGICAL POWER TOOLS

7.2.3.1 DRILL

7.2.3.1.1 PNEUMATIC NEUROSURGICAL DRILLS

7.2.3.1.2 ELECTRICAL NEUROSURGICAL DRILLS

7.2.3.2 SAW

7.2.3.3 OTHERS

7.2.4 NEUROSURGICAL NAVIGATION SYSTEMS

7.2.5 CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES

7.2.5.1 CSF SHUNTS

7.2.5.2 EXTERNAL DRAINAGE SYSTEM

7.2.6 NEUROSURGICAL MICROSCOPE

7.2.7 CRANIAL STABILIZATION

7.2.8 NEUROENDOSCOPY DEVICES

7.2.9 INTRA OPERATIVE IMAGING

7.2.10 BRAIN MONITORING

7.2.11 NEUROSURGICAL EVACUATION DEVICES

7.2.12 STEREOTACTIC SYSTEMS

7.2.13 ULTRASONIC ASPIRATOR

7.2.14 BIPOLAR EQUIPMENT

7.3 NEUROSURGERY SOFTWARE

7.3.1 IMAGING NEUROSURGERY SOFTWARE

7.3.2 PRE-OPERATION PLANNING NEUROSURGERY SOFTWARE

7.3.3 OTHERS

7.4 CONSUMABLES

8 NORTH AMERICA NEUROSURGERY MARKET, BY AGE GROUP

8.1 OVERVIEW

8.2 PEDIATRIC

8.3 ADULT

8.4 GERIATRIC

9 NORTH AMERICA NEUROSURGERY MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 BRAIN TUMORS

9.3 TRAUMA SURGERY

9.4 SPINE SURGERY

9.5 PARKINSON’S DISEASE AND TREMORS

9.6 PERIPHERAL NERVE SURGERY

9.7 EPILEPSY

9.8 FUNCTIONAL NEUROSURGERY

9.9 CAROTID ARTERY BLOCKAGE/STENOSIS

9.1 INTRAOPERATIVE ANGIOGRAPHY

9.11 CEREBROVASCULAR SURGERY

9.12 ANEURYSMS

9.13 PITUITARY TUMORS

9.14 RADIOSURGERY

9.15 STEREOTACTIC NEUROSURGERY

9.16 CORTICAL MAPPING

9.17 ARTERIOVENOUS MALFUNCTION (AVM)

9.18 SKULL BASE SURGERY

9.19 TRIGEMINAL NEURALGIA

9.2 OTHERS

10 NORTH AMERICA NEUROSURGERY MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 ACUTE CARE HOSPITALS

10.2.2 LONG-TERM CARE HOSPITALS

10.2.3 NURSING FACILITIES

10.2.4 REHABILITATION CENTERS

10.3 RESEARCH CENTERS

10.4 NEUROSURGERY CENTERS

10.5 AMBULATORY SURGICAL CENTERS (ASCS)

10.6 OTHERS

11 NORTH AMERICA NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 THIRD PARTY DISTRIBUTORS

11.4 OTHERS

12 NORTH AMERICA NEUROSURGERY MARKET, BY REGION

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA NEUROSURGERY MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 MEDTRONIC

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 STRYKER

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 ABBOTT

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENTS

15.5 INTEGRA LIFESCIENCES (2021)

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 ADEOR MEDICAL AG

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENTS

15.7 ADVANTIS MEDICAL IMAGING

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENT

15.8 ALEVA NEUROTHERAPEUTICS

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENTS

15.9 ANT NEURO

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 B. BRAUN SE

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 BIOINDUCTION

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 BRAINLAB AG

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 ELEKTA

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENTS

15.14 EMS HANDELS GESELLSCHAFT MBH

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 INOMED MEDIZINTECHNIK GMBH

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 KARL STORZ SE & CO. KG

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 LEICA MICROSYSTEMS

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENT

15.18 LIVANOVA PLC

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 NEVRO CORP.

15.19.1 COMPANY SNAPSHOT

15.19.2 REVENUE ANALYSIS

15.19.3 PRODUCT PORTFOLIO

15.19.4 RECENT DEVELOPMENTS

15.2 OPTOFINE INSTRUMENTS PVT. LTD.

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 PENUMBRA, INC.

15.21.1 COMPANY SNAPSHOT

15.21.2 REVENUE ANALYSIS

15.21.3 PRODUCT PORTFOLIO

15.21.4 RECENT DEVELOPMENTS

15.22 RENISHAW PLC.

15.22.1 COMPANY SNAPSHOT

15.22.2 REVENUE ANALYSIS

15.22.3 PRODUCT PORTFOLIO

15.22.4 RECENT DEVELOPMENT

15.23 SYNAPSE BIOMEDICAL INC.

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENT

15.24 TERUMO MEDICAL CORPORATION

15.24.1 COMPANY SNAPSHOT

15.24.2 REVENUE ANALYSIS

15.24.3 PRODUCT PORTFOLIO

15.24.4 RECENT DEVELOPMENTS

15.25 MACHIDA ENDOSCOPE CO., LTD.

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

15.26 NALU MEDICAL, INC.

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENT

15.27 WALLABY MEDICAL

15.27.1 COMPANY SNAPSHOT

15.27.2 PRODUCT PORTFOLIO

15.27.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 NORTH AMERICA NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 NORTH AMERICA NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA INTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA SPINAL CORD STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA EXTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA NEURO-INTERVENTIONAL DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA EMBOLIZATION COILS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA NEUROVASCULAR THROMBECTOMY IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA NEUROSURGICAL POWER TOOLS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA DRILL IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA CONSUMABLES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA NEUROSURGERY MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA PEDIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA ADULT IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA GERIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA NEUROSURGERY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA BRAIN TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA TRAUMA SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA SPINE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA PARKINSON’S DISEASE AND TREMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA PERIPHERAL NERVE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA EPILEPSY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA FUNCTIONAL NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA CAROTID ARTERY BLOCKAGE/STENOSIS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA INTERAOPERATIVE ANGIOGRAPHY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA CEREBROVASCULAR SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA ANEURYSMS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA PITUITARY TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA RADIOSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA STEREOTACTIC NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA CORTICAL MAPPING IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA ARTERIOVENOUS MALFUNCTION (AVM) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA SKULL BASE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA TRIGEMINAL NEURALGIA IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA HOSPITALS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA HOSPITALS IN NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA RESEARCH CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA NEUROSURGERY CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA AMBULATORY SURGICAL CENTERS (ASCS) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 NORTH AMERICA OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 NORTH AMERICA NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 53 NORTH AMERICA DIRECT TENDER IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 54 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 55 NORTH AMERICA OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA NEUROSURGERY MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA NEUROSURGERY MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA NEUROSURGERY MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA NEUROSURGERY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 NORTH AMERICA NEUROSURGERY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA NEUROSURGERY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA NEUROSURGERY MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 NORTH AMERICA NEUROSURGERY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA NEUROSURGERY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA NEUROSURGERY MARKET: SEGMENTATION

FIGURE 11 THE GROWING PREVALENCE OF NEUROLOGICAL DISEASES, EFFORTS TO DEVELOP THE APPLICATION BASE FOR NEUROMODULATION, AND THE BENEFITS OF NEUROENDOSCOPIC SURGERIES OVER CONVENTIONAL BRAIN SURGERIES ARE EXPECTED TO DRIVE THE NORTH AMERICA NEUROSURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 NEUROSURGERY DEVICES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NEUROSURGERY MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND, CHALLENGES OF NORTH AMERICA NEUROSURGERY MARKET

FIGURE 14 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE, 2021

FIGURE 15 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 16 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 17 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA NEUROSURGERY MARKET: BY AGE GROUP, 2021

FIGURE 19 NORTH AMERICA NEUROSURGERY MARKET: BY AGE GROUP, 2022-2029 (USD MILLION)

FIGURE 20 NORTH AMERICA NEUROSURGERY MARKET: BY AGE GROUP, CAGR (2022-2029)

FIGURE 21 NORTH AMERICA NEUROSURGERY MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 22 NORTH AMERICA NEUROSURGERY MARKET: BY APPLICATION, 2021

FIGURE 23 NORTH AMERICA NEUROSURGERY MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 24 NORTH AMERICA NEUROSURGERY MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 25 NORTH AMERICA NEUROSURGERY MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 NORTH AMERICA NEUROSURGERY MARKET: BY END USER, 2021

FIGURE 27 NORTH AMERICA NEUROSURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 28 NORTH AMERICA NEUROSURGERY MARKET: BY END USER, CAGR (2022-2029)

FIGURE 29 NORTH AMERICA NEUROSURGERY MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 NORTH AMERICA NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 31 NORTH AMERICA NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 32 NORTH AMERICA NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 33 NORTH AMERICA NEUROSURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 NORTH AMERICA NEUROSURGERY MARKET: SNAPSHOT (2021)

FIGURE 35 NORTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021)

FIGURE 36 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT COUNTRY (2022 & 2029)

FIGURE 37 NORTH AMERICA NEUROSURGERY MARKET: BY COUNTRY (2021 & 2029)

FIGURE 38 NORTH AMERICA NEUROSURGERY MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 39 NORTH AMERICA NEUROSURGERY MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.